Hot Pursuit     06-Feb-25
Zydus Lifesciences Ltd gains for third straight session
Zydus Lifesciences Ltd is quoting at Rs 1018.55, up 4.25% on the day as on 12:49 IST on the NSE. The stock is up 28.67% in last one year as compared to a 7.61% jump in NIFTY and a 18.78% jump in the Nifty Pharma index.

Zydus Lifesciences Ltd gained for a third straight session today. The stock is quoting at Rs 1018.55, up 4.25% on the day as on 12:49 IST on the NSE. The benchmark NIFTY is down around 0.41% on the day, quoting at 23600.05. The Sensex is at 77920.62, down 0.45%. Zydus Lifesciences Ltd has gained around 1.77% in last one month.

Meanwhile, Nifty Pharma index of which Zydus Lifesciences Ltd is a constituent, has gained around 5.07% in last one month and is currently quoting at 21868.5, up 0.83% on the day. The volume in the stock stood at 41.26 lakh shares today, compared to the daily average of 12.66 lakh shares in last one month.

The benchmark February futures contract for the stock is quoting at Rs 1018.65, up 3.95% on the day. Zydus Lifesciences Ltd is up 28.67% in last one year as compared to a 7.61% jump in NIFTY and a 18.78% jump in the Nifty Pharma index.

The PE of the stock is 22.51 based on TTM earnings ending December 24.

Previous News
  Sentynl (Zydus Group) receives USFDA approval for ZYCUBO®
 ( Corporate News - 13-Jan-26   14:01 )
  Zydus Lifesciences’ US arm secures FDA nod for ZYCUBO in Pediatric Menkes Patients
 ( Hot Pursuit - 13-Jan-26   11:17 )
  Zydus Lifesciences Ltd spurts 0.27%, up for fifth straight session
 ( Hot Pursuit - 06-Jan-26   13:00 )
  Zydus partners with Bioeq for licensing, supply and commercialization of Lucentis® in US market
 ( Corporate News - 23-Dec-25   19:05 )
  Zydus signs agreement with Myriad Genetics
 ( Corporate News - 19-Dec-25   10:22 )
  Sentynl announces USFDA Acceptance of CUTX-101 NDA resubmission
 ( Corporate News - 15-Dec-25   19:03 )
  Zydus Lifesciences gains after launching Denosumab Biosimilar
 ( Hot Pursuit - 10-Dec-25   11:27 )
  Zydus launches Zyrifa - a Denosumab biosimilar
 ( Corporate News - 10-Dec-25   10:19 )
  Zydus Lifesciences receives EIR for facility at Jarod, Vadodara
 ( Corporate News - 04-Dec-25   15:48 )
  Zydus Life gets US FDA nod for generic version of antidiabetic combination drug Glyxambi
 ( Hot Pursuit - 28-Nov-25   09:21 )
  Zydus Life rises after inking exclusive licensing deal with RK Pharma for US oncology product
 ( Hot Pursuit - 26-Nov-25   13:30 )
Other Stories
  ICICI Prudential Life Insurance Q3 PAT climbs 20% YoY to Rs 390 cr
  13-Jan-26   18:19
  Bank of Maharashtra gains as Q3 PAT climbs 27% YoY to Rs 1,779 cr
  13-Jan-26   15:27
  TVS Supply Chain Solutions jumps after bagging 3-year contract from Daimler India
  13-Jan-26   15:11
  Dixon Technologies (India) Ltd leads losers in 'A' group
  13-Jan-26   15:00
  L&T slips on Kuwait tender rebid reports; company says projects not in order book
  13-Jan-26   14:54
  Karma Energy Ltd leads losers in 'B' group
  13-Jan-26   14:45
  Volumes jump at ITI Ltd counter
  13-Jan-26   14:30
  Indo Thai Securities gains as Q3 PAT soars 1,629% YoY to Rs 17 crore
  13-Jan-26   14:11
  Puravankara's subsidiary bags LoI for residential project in Bangalore worth Rs 311.18 crore
  13-Jan-26   13:40
  Hero MotoCorp Ltd down for fifth straight session
  13-Jan-26   13:35
Back Top